emat

Buy Complete Report

Prix: €120 HT

Logo CreditCards Visa Logo CreditCards Mastercard

This report is accessible on EMAT, the reference database for private company acquisition multiples

 

 

► Subscribe to EMAT database

 

Sectors covered by our analysts

 

► Studies & indices published by Epsilon Research: Register to receive (free) publications updates

 

► Alert on reports published: Sign up (free) to receive by e-mail updates on EMAT reports published on your preferred sector.

 

Transaction Multiples for the Valuation of Private Companies

Groupe Vabel / Laboratoires Sarbec

No EMAT : 113988
Announced Date : 18/07/2023
Type : Acquisition of Majority Stake
Deal Value : Yes
Acquirer : Groupe Vabel

Target : Laboratoires Sarbec
Country : Nord
Sector of activity :
  • Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Personal Products
Business Description :
Founded in 1974 by Patrick Van Den Schrieck, Laboratoires Sarbec manufactures and distributes cosmetics, personal hygiene products and perfumes. > Products in the following areas: Cosmectics...

Transaction multiples available
EV/
Sales
EV/
Gross Profit
EV/
EBITDA
EV/
EBIT
Eq/
PBT
P/E Price
to Book
Specific
multiple(s)
Historic
Current
Rating : *
Multiple available
n.s.   Multiple calculated, but not significant

Source: Epsilon Research / EMAT

Comparable Transactions

  • Number of EMAT Reports / sub-sector « Personal Products » = 129
Example of comparable transactions on EMAT (same sub-sector):
Date Acquirer Target Country Multiples See details
24/04/2020 Orifarm Group Takeda Pharmaceutical's OTC and prescription pharmaceutical products in Europe Europe ** 113870
10/11/2020 Cooper Consumer Health Laboratoire Tradiphar Nord ** 113842

Source: Epsilon Research / EMAT

About Epsilon Research

Epsilon Research is an independent research and financial analysis bureau, and the reference source of transaction multiples for the valuation of private companies through its EMAT database.

EMAT Report

► Each EMAT Report includes the detailed analysis of the transaction: deal rationale and structure, target business lines and financials (restated), valuation multiples (calculation and analysis).

 

► Example of EMAT Report